FDA Regulation Of Mifepristone ‘Subverts’ Dobbs, Plaintiffs Tell 5th Circuit
NEW ORLEANS — Eight anti-abortion plaintiffs tell the Fifth Circuit U.S. Court of Appeals that the Food and Drug Administration’s approval and regulation of the abortion drug mifepristone subverts Dobbs v....To view the full article, register now.
Already a subscriber? Click here to view full article